Alex J. Eustace
0000-0002-4092-1360
Dublin City University
7 papers found
Refreshing results…
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
Effects of HER family-targeting tyrosine kinase inhibitors on antibody-dependent cell-mediated cytotoxicity in HER2-expressing breast cancer
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL
Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer
Missing publications? Search for publications with a matching author name.